1 harnessed to generate antibodies with potent antiaggregation.

2 active alkaloid, annotinolide A, which shows antiaggregation activity against amyloid-beta (Abeta)1-4

3 he deletion mutant was a 10-fold increase in antiaggregation activity.

4   Recently, intrabodies have shown promising antiaggregation and neuroprotective effects against misf

5  chaperonin rings are not obligate confining antiaggregation cages.

6 opose that zinc adopts the role of a minimal antiaggregation chaperone for Abeta40.

7 nt antithrombotic effect superimposed on the antiaggregation characteristics.

8  to the use of natural products as effective antiaggregation compounds, directly targeting Abeta.

9                                              Antiaggregation drugs play an important role in therapeu

10 change Abeta(10-40) secondary structure, its antiaggregation effect is likely to be weak.

11 ynucleinopathy and demonstrate a significant antiaggregation effect on alpha-synuclein.

12 ta, we propose a rationale for the ibuprofen antiaggregation effect.

13 eded an understanding of the recognition and antiaggregation mechanisms.

14 ult males produce frontalin, an eight-carbon antiaggregation pheromone, via the mevalonate pathway, a

15 s, we conclude that this ligand has stronger antiaggregation potential against Abeta fibrils rather t

16 III flagellar protein export system that has antiaggregation properties and several other characteris

17 fication of His in the peptide abolishes the antiaggregation property of the mini-chaperone.

18 ELKVK is necessary to completely abolish the antiaggregation property of the peptide in insulin reduc